Top Markets
Coin of the day
Crossject Société Anonyme Crossject Société Anonyme

Crossject Société Anonyme

ALCJ
Rank in Stocks #12744
Crossject Société Anonyme develops needle-free injection systems. The company... Crossject Société Anonyme develops needle-free injection systems. The company develops ZENEO, a needle-free, prefilled, and single-use auto-injector. Its clinical stage drugs comprise Sumatriptan, which is used for of treatment migraines and cluster headaches; Adrenaline for treating anaphylactic shock; Hydrocortisone that is used for treatment of acute adrenal crisis; Midazolam for treating epileptic seizure; Naloxone used for treatment of overdose; Apomorphine, for treating temporary paralysis in parkinson's disease; Methotrexate used for treatment of rheumatoid arthritis; and Terbutaline, for treating severe asthma crisis. The company was founded in 1997 and is based in Dijon, France.
Share Price
$2.02
Market Cap
$121.30M
Change (1 day)
-1.04%
Change (1 year)
-2.09%
Country
FR
Trade Crossject Société Anonyme (ALCJ)

Category

Stock split history for Crossject Société Anonyme (ALCJ)
Crossject Société Anonyme stock (symbol: ALCJ) underwent a total of 2 stock splits.
The most recent stock split occurred on Nov 29, 2018.
One ALCJ share bought prior to Mar 14, 2017 would equal to 1.046448 ALCJ shares today.
Stock split list
Year Split Multiple Cumulative Multiple
2018-11-29 129:125 x1.032 x1.046448
2017-03-14 507:500 x1.014 x1.014
Stock splits for similar companies or competitors